Dr. Ahmed O Kaseb graduated in 1996 (MBBS) from Cairo University School of Medicine, Egypt. After graduation, Dr. Kaseb began working at the University of Michigan, Ann Arbor, as a research fellow focusing on oncogenic viruses and cancer biomarkers. Later, he joined the MD Anderson Cancer Center in Houston, Texas, as an assistant professor of GI Medical Oncology, to focus on hepatobiliary malignancies in July 2007. His primary research interest is identifying some of the key prognostic and predictive molecular biomarkers that underlie malignant development and progression of HCC. Dr. Kaseb is interested to develop more informative prognostic and predictive molecular staging systems for HCC, with priority efforts given to the identification and characterization of potential targets for therapeutic intervention. Dr. Ahmed O Kaseb graduated in 1996 (MBBS) from Cairo University School of Medicine, Egypt. After graduation, Dr. Kaseb began working at the University of Michigan, Ann Arbor, as a research fellow focusing on oncogenic viruses and cancer biomarkers. Later, he joined the MD Anderson Cancer Center in Houston, Texas, as an assistant professor of GI Medical Oncology, to focus on hepatobiliary malignancies in July 2007. His primary research interest is identifying some of the key prognostic and predictive molecular biomarkers that underlie malignant development and progression of HCC. Dr. Kaseb is interested to develop more informative prognostic and predictive molecular staging systems for HCC, with priority efforts given to the identification and characterization of potential targets for therapeutic intervention.

cancer biomarker, Oncology